Butterfly Network

The stock of Butterfly Network rose to a 52-week high of $9.74 and is currently trading around $9.77, implying a market capitalization of about $2.57 billion and a 1-year performance of +601.47%. Data from InvestingPro view the stock as significantly above its fair value and point to a high beta of 2.08, indicating considerable volatility. In Q2 2026 the company reported adjusted EPS of -$0.01 (better than expected) on revenue of $15.72 million (below expectations), but raised its full-year outlook and highlighted a record quarter with stronger margins and higher US sales. » More on de.investing.com

Butterfly Network replaces traditional ultrasound crystals with a low-cost silicon microchip, transforming medical imaging. The company is shifting from a hardware provider to a platform, with cloud and AI software revenues already making up more than 40% of sales. A planned push into at-home patient monitoring from late 2026 is expected to open large future markets, but the stock remains speculative. » More on finanzen.net

Butterfly Network said the prototype Midjourney scanner integrates 40 Ultrasound‑on‑Chip modules and future versions will scale to many more. CEO Joseph DeVivo described the system as a whole‑body scanner using roughly half a million sensors and over two petaflops of processing power, operating without radiation or magnetic risk and designed for frequent monitoring. Butterfly signaled commercial potential in Midjourney's roadmap and noted a prior co‑development agreement that could yield up to $74 million in payments over five years. » More on finance.yahoo.com